NCT07915765Not yet recruiting
Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
This non-interventional study aims to assess the impact of an endometriosis diagnosis obtained through a salivary test (Ziwig Endotest®) on pain-related cognitions, quality of life, mood, and treatment adherence, comparingthese outcomes with those of individuals who underwent the same salivary test but received a negative result and were therefore not diagnosed with endometriosis. Participation in this study will contribute to advancing research in the field of endometriosis diagnosis and multidisciplinary management by expanding current knowledge of diagnostic protocols and their impact on pain, quality of life, treatment adherence, and potential psychiatric comorbidities. The investigators hope to enhance understanding of endometriosis and pelvic pain symptomatology in order to develop new therapeutic strategies, including psychological interventions or integrated psychological care, that better address the needs and specific characteristics of patients whether or not they receive a diagnosis of endometriosis.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 14 Oct 2026
- Start date
- Nov 2026
- Primary completion date
- Jun 2028
- Lead sponsor
- University Hospital, Lille
- Diseases
- Endometriosis
- NCT number
- NCT07915765
What you commit to
- Study type: Observational
- Planned participants: 50
- From Nov 2026 to the primary completion date, Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Refusal to participate after receiving clear and fair information about the study
- Use of psychotropic medications
Other illness
- Personal history of neurological disorders or current neurological disorder
- Personal history of psychiatric disorders or current psychiatric disorders other than anxiety, depressive, or trauma- and stress-related disorders
Other
- Minors, adults under guardianship, under judicial protection, and persons deprived of liberty
- Sensory, visual or auditory inability to participate in the study
- Consumtion of toxic substances other than tobacco and alcohol.
- Pregnant or breastfeeding women
Who the study is looking for
- Patients eligible for an endotest as part of the innovation package at Jeanne de Flandre Hospital
- Patients between 18 to 43 years old
- Understand and can communicate in French
- Having received medical images that do not allow the diagnosis of endometriosis
- Presenting with symptoms suggestive of endometriosis
- Giving oral non-opposition to participe in the study
- Beneficiary of health insurance coverage
- Having normal visual and auditory acuity or corrected to normal levels
Age in the registry: 18 years to 43 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Lille Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.